Pharmacokinetic, Pharmacodynamic, and Drug-Interaction Profile of Remdesivir, a SARS-CoV-2 Replication Inhibitor-Reference-Cited by-同舟云学术

Pharmacokinetic, Pharmacodynamic, and Drug-Interaction Profile of Remdesivir, a SARS-CoV-2 Replication Inhibitor

Published:2021-03-30 Issue:5 Volume:60 Page:569-583
ISSN:0312-5963
Container-title:Clinical Pharmacokinetics
language:en
Short-container-title:Clin Pharmacokinet

Author:

Humeniuk Rita^ORCID,Mathias Anita,Kirby Brian J.,Lutz Justin D.,Cao Huyen,Osinusi Anu,Babusis Darius,Porter Danielle,Wei Xuelian,Ling John,Reddy Y. Sunila,German Polina

Funder

Gilead Sciences

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology

Link

https://link.springer.com/content/pdf/10.1007/s40262-021-00984-5.pdf

Reference46 articles.

1. Humeniuk R, Mathias A, Cao H, Osinusi A, Shen G, Chng E, et al. Safety, tolerability, and pharmacokinetics of remdesivir, an antiviral for treatment of COVID-19, in healthy subjects. Clin Transl Sci. 2020;13(5):896–906. https://doi.org/10.1111/cts.12840.

2. WHO. Timeline of WHO’s response to COVID-19. https://www.who.int/news-room/detail/29-06-2020-covidtimeline. Accessed 16 Aug 2020.

3. Vellingiri B, Jayaramayya K, Iyer M, Narayanasamy A, Govindasamy V, Giridharan B, et al. COVID-19: a promising cure for the global panic. Sci Total Environ. 2020;725:138277.

4. Harapan H, Itoh N, Yufika A, et al. Coronavirus disease 2019 (COVID-19): a literature review. J Infect Public Health. 2020;13:667–73.

5. Rothan HA, Byrareddy SN. The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. J Autoimmun. 2020;109:102433.

Cited by 92 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drug-Drug Interactions between COVID-19 and Tuberculosis Medications: A Comprehensive Review of CYP450 and Transporter-Mediated Effects;Pharmaceuticals;2024-08-06

2. Severe Myocardium Suppression in Two Congenital Heart Disease Patients After Remdesivir Use;2024-07-19

3. Pharmacokinetics, Mass Balance, Safety, and Tolerability of Obeldesivir in Healthy Participants;Clinical Pharmacology & Therapeutics;2024-06-28

4. Efficacy and Safety of Remdesivir in People With Impaired Kidney Function Hospitalized for Coronavirus Disease 2019 Pneumonia: A Randomized Clinical Trial;Clinical Infectious Diseases;2024-06-24

5. COVID-19 therapeutics;Clinical Microbiology Reviews;2024-06-13